
Audiocast
Q3 2020 Dealmaker Roundup
An in-depth discussion among private equity leaders addressing the winners and losers in the food and beverage industry during COVID-19.
An in-depth discussion among private equity leaders addressing the winners and losers in the food and beverage industry during COVID-19.
An in-depth discussion between two technology industry veterans: Richard Lawson, Co-Founder of HGGC and David Van Wert of RSM.
How is disruption in the health care industry impacting patients? RSM experts discuss this important trend. Listen and learn.
As PE firms are increasingly investing in healthcare businesses, what are the economics of such deals on doctors? Listen and learn.
Three veterans of the life sciences private equity and M&A market share intel about dramatic changes in the industry.
With strong dealmaking in Q1 2019, a panel of private equity deal experts discuss the trends behind the numbers and outcomes.
As software has grown exponentially as an industry, private capital has flowed into the sector in greater and greater amounts.
An in-depth discussion addressing health care deals during COVID-19, the surge of telemedicine and the business of hospitals.
IPOs surge as valuation fatigue sets in: A panel of private equity deal experts discuss the trends behind the Q2 2019 numbers and outcomes.
A panel of private equity deal experts address Q3 deal activity and share thoughts on investment opportunities in financial services.
An in-depth discussion among PE leaders addressing the effects of COVID-19, technology and a disrupted supply chain on U.S. manufacturing.